173 related articles for article (PubMed ID: 37089398)
1. Incidence and prognostic nomogram for resected non-small cell neuroendocrine tumor: A population-based respective study in China and the SEER database.
Liu Y; Yang M; Pang Z; Zhao X; Ma G; Zhao Q; Du J
Heliyon; 2023 Apr; 9(4):e15319. PubMed ID: 37089398
[TBL] [Abstract][Full Text] [Related]
2. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database.
Yang L; Zhou Y; Wang G; Liu D; Chen B; Pu D; Correale P; Rades D; Tomita Y; Inno A; Santarpia M; Li Y; Li W
Transl Lung Cancer Res; 2021 Nov; 10(11):4250-4265. PubMed ID: 35004254
[TBL] [Abstract][Full Text] [Related]
4. A prognostic nomogram to predict survival in elderly patients with small-cell lung cancer: a large population-based cohort study and external validation.
Lu G; Li J; Ruan Y; Shi Y; Zhang X; Xia Y; Zhu Z; Lin J; Li L
BMC Cancer; 2022 Dec; 22(1):1271. PubMed ID: 36474197
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.
Liang M; Chen M; Singh S; Singh S
Adv Ther; 2022 Jan; 39(1):346-359. PubMed ID: 34729705
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Nomogram for Predicting Overall Survival in Patients with Second Primary Small Cell Lung Cancer After Non-Small Cell Lung Cancer: A SEER-Based Study.
Zhu J; Shi H; Ran H; Lai Q; Shao Y; Wu Q
Int J Gen Med; 2022; 15():3613-3624. PubMed ID: 35401011
[TBL] [Abstract][Full Text] [Related]
7. A novel nomogram predicting cancer-specific survival in small cell lung cancer patients with brain metastasis.
Rong YT; Zhu YC; Wu Y
Transl Cancer Res; 2022 Dec; 11(12):4289-4302. PubMed ID: 36644187
[TBL] [Abstract][Full Text] [Related]
8. Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study.
Jiang A; Liu N; Zhao R; Liu S; Gao H; Wang J; Zheng X; Ren M; Fu X; Liang X; Tian T; Ruan Z; Yao Y
Cancer Control; 2021; 28():10732748211051228. PubMed ID: 34632799
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort.
Wang Q; Wang Y; Wang X; Nakamura Y; Hydbring P; Yamauchi Y; Zhao X; Cao M
Transl Lung Cancer Res; 2022 Aug; 11(8):1678-1691. PubMed ID: 36090634
[TBL] [Abstract][Full Text] [Related]
10. Effect of pleural invasion on survival of patients with small cell lung cancer: Propensity score analysis and nomogram establishment based on the SEER database.
Yang J; Yin H; Liu M; Zou G; Yu B
Front Surg; 2023; 10():1108732. PubMed ID: 36911624
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: a study based on the SEER database and a Chinese cohort.
Zhou L; Zhang Y; Chen W; Niu N; Zhao J; Qi W; Xu Y
BMC Cancer; 2022 Sep; 22(1):980. PubMed ID: 36104656
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of nomogram prognostic model for early-stage T1-2N0M0 small cell lung cancer: A population-based analysis.
Ge T; Zhu S; Sun L; Yin L; Dai J; Qian J; Chen X; Zhang P; Zhu J; Jiang G
Front Oncol; 2022; 12():921365. PubMed ID: 36465408
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a prognostic model of resectable small-cell lung cancer: a large population-based cohort study and external validation.
Wang Y; Pang Z; Chen X; Yan T; Liu J; Du J
J Transl Med; 2020 Jun; 18(1):237. PubMed ID: 32539859
[TBL] [Abstract][Full Text] [Related]
14. Prognostic nomogram and novel risk-scoring system for small cell lung cancer with different patterns of metastases.
Ruan H; Sun H; Guo Y; Ding Y; Liu Y; Ying S; Lin P
Gen Thorac Cardiovasc Surg; 2022 Dec; 70(12):1022-1031. PubMed ID: 35716296
[TBL] [Abstract][Full Text] [Related]
15. The prognostic risk stratification model for metastatic small-cell lung cancer: An analysis of the SEER database.
Qie S; Shi H; Wang F; Liu F; Zhang X; Li Y; Sun X
Medicine (Baltimore); 2022 Oct; 101(42):e31000. PubMed ID: 36281112
[TBL] [Abstract][Full Text] [Related]
16. Construction and validation of a nomogram to predict the overall survival of small cell lung cancer: a multicenter retrospective study in Shandong province, China.
Song Z; Ma H; Sun H; Li Q; Liu Y; Xie J; Feng Y; Shang Y; Ma K; Zhang N; Wang J
BMC Cancer; 2023 Dec; 23(1):1182. PubMed ID: 38041067
[TBL] [Abstract][Full Text] [Related]
17. Establishment and Validation of a Predictive Nomogram for Postoperative Survival of Stage I Non-Small Cell Lung Cancer.
Wang ZH; Deng L
Int J Gen Med; 2022; 15():7287-7298. PubMed ID: 36133910
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
[TBL] [Abstract][Full Text] [Related]
19. A novel LASSO-derived prognostic model predicting survival for non-small cell lung cancer patients with M1a diseases.
Chen H; Huang C; Ge H; Chen Q; Chen J; Li Y; Chen H; Luo S; Zhao L; Xu X
Cancer Med; 2022 Mar; 11(6):1561-1572. PubMed ID: 35128839
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a nomogram for predicting survival time and making treatment decisions for clinical stage IA NSCLC based on the SEER database.
Xu B; Ye Z; Zhu L; Xu C; Lu M; Wang Q; Yao W; Zhu Z
Front Med (Lausanne); 2022; 9():972879. PubMed ID: 36619647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
